Facilitators and Barriers to Uptake of Drug–Drug Interaction Alerts: Perspectives of Australian End Users and Managers
Applied Clinical Informatics · 01.03.2025 · 16 (02) · 295-304
DOI: 10.1055/a-2481-4221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Clinical Informatics, erschienen am 01.03.2025. Verfasst von Kristian Stanceski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, Biomedical Informatics and Digital Health, School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine an…. Hauptthemen laut MEDLINE: Medical Order Entry Systems, Attitude of Health Personnel. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Drug–drug interaction (DDI) alerts in electronic systems are frequently implemented to minimize the occurrence of preventable DDIs. While prescribers recognize the potential benefits of DDI alerts, a large proportion are overridden by users.
Objectives
This study aimed to explore and compare prescribers' and managers' perspectives of DDI alerts.
Methods
A qualitative descriptive study was conducted across six hospitals in Australia with end users (prescribers who receive alerts) [n = 14] and managers [n = 20] (senior staff in roles relevant to alert system implementation and management). End users were asked to reflect on alert usefulness, benefits, risks, and impacts. Managers were asked what they thought of alerts, and about any feedback they had received from frontline clinicians. Key themes were extracted via an inductive content analysis approach and deductively mapped to the Technology Acceptance Model (TAM3). Comparisons of the views held toward the alerts were made between the two participant groups.
Results
End users predominantly reflected on the utility of the DDI alert system (i.e. how useful it was to their role), less on how easy the system was to use, and mainly focused on the negative consequences of alerts. Managers believed the benefits of DDI alerts are primarily experienced by junior doctors. While end users suggested that alerts should be tailored to the patient's clinical scenario, managers called for DDI alerts to be tailored to the prescriber (seniority and specialty).
Conclusion
Interviews with end users and managers uncovered a number of perceived benefits and limitations of DDI alerts, primarily related to the system's usefulness. While largely consistent, some perceptions were different between end users and managers, particularly in the types of benefits, and how they conceptualized potential tailoring to improve DDI alerts. Our findings point to a need for user participation in the development, deployment, and improvement of alerts to promote consideration and effectiveness of DDI alerts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine and Health, Biomedical Informatics and Digital Health, School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
- Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
- Clinical Pharmacology & Toxicology, St Vincent's Clinical School, The University of New South Wales, St Vincent's Clinical Campus, St Vincent's Hospital, Victoria Street, Darlinghurst, New South Wales, Australia.
- Departments of Clinical Pharmacology and Aged Care, Kolling Institute of Medical Research, Faculty of Medicine and Health, The University of Sydney and Northern Sydney Local Health District, St Leonards, New South Wales…
- Departments of Clinical Pharmacology and Aged Care, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Zitieren
APA
Stanceski, K., Van Dort, B. A., Lee, T., McLachlan, A. J., Day, R. O., Hilmer, S. N., Li, L., Westbrook, J., Zheng, W. Y., Barras, M., Mekhail, K. Z. S., & Baysari, M. T. (2025). Facilitators and Barriers to Uptake of Drug–Drug Interaction Alerts: Perspectives of Australian End Users and Managers. Applied Clinical Informatics, 16(02), 295-304. https://doi.org/10.1055/a-2481-4221
Vancouver
Stanceski K, Van Dort BA, Lee T, McLachlan AJ, Day RO, Hilmer SN, et al. Facilitators and Barriers to Uptake of Drug–Drug Interaction Alerts: Perspectives of Australian End Users and Managers. Applied Clinical Informatics. 2025;16(02):295-304. doi:10.1055/a-2481-4221
BibTeX
@article{Stanceski2025,
author = {Stanceski, Kristian and Van Dort, Bethany A and Lee, Teresa and McLachlan, Andrew J and Day, Richard O and Hilmer, Sarah N and Li, Ling and Westbrook, Johanna and Zheng, Wu Yi and Barras, Michael and Mekhail, Karma Z S and Baysari, Melissa T},
title = {Facilitators and Barriers to Uptake of Drug–Drug Interaction Alerts: Perspectives of Australian End Users and Managers},
journal = {Applied Clinical Informatics},
year = {2025},
volume = {16},
number = {02},
pages = {295--304},
doi = {10.1055/a-2481-4221}
}
EUVIMED